$USPH

Minan Peter Francis purchased $49K of USPH

Minan Peter Francis purchased 780 shares of U S PHYSICAL THERAPY INC /NV (USPH) at an average of $62.53 ($61.50–$63.14) across 2 trades over 2026-06-08 to 2026-06-09.

Original reporting
SEC EDGAR · Minan Peter Francis
Published Jun 10, 2026, 10:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 10, 2026, 10:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$USPH
Bullish
low confidence
Mentioned
$USPH
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$USPHBullishLow
01

Why it matters

Traders may treat the buy as a small sentiment input, but without new guidance, contracts, or regulatory developments, it is unlikely to drive a sustained repricing.

02

Market read

New insider-buy disclosure (director open-market purchase) with modest size; useful for sentiment/flow checks rather than a standalone catalyst.

03

What to watch

The article provides only the transaction details (size, price range, post-holdings) without context on prior holdings, compensation timing, or whether other insiders acted.

Relevance 4/10Novelty 8/10Timing: Filed 2026-06-10 for trades dated 2026-06-08 to 2026-06-09

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for U S Physical Therapy Inc /NV (USPH).

Company-level read

Ticker impact

$USPHBullishLow confidence
Context

SEC Form 4 shows director Minan Peter Francis bought 780 shares of U S Physical Therapy (USPH) in open-market trades for ~$48.8K.

Expected impact

Likely limited near-term impact; any effect is more sentiment/positioning than a re-rating catalyst.

Evidence & confidence

The filing is a routine insider buy with relatively small dollar value and no accompanying operational/regulatory update in the text.

Market effects

No sector-wide read-through; this is company-specific insider activity only.

None indicated.

None indicated.

Counterpoint

Insider buys can be driven by diversification, liquidity needs, or routine planned activity; this filing explicitly notes no 10b5-1 plan, but that still doesn’t confirm conviction.

Key entities

  • U S Physical Therapy Inc /NV

    Subject of the Form 4 insider transaction disclosure.

  • Minan Peter Francis

    Director who executed open-market purchases of USPH shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$USPHMed

US Physical Therapy (USPH) Taps A Global Finance Veteran As CFO

US Physical Therapy (USPH) appointed Nchacha Etta as CFO, effective September 1. Etta previously held CFO roles at Omnicell (OMCL) and Johnson & Johnson Vision. USPH reported Q2 2026 revenue of $214.1M, up 8.5%, but net income fell to $9.9M from $12.4M. The company reaffirmed full-year adjusted EBITDA guidance of $102M-$106M.

$USPHMedAI 8/10

USPH (USPH) Q2 2026 Earnings Call Transcript

US Physical Therapy (USPH) discussed its Q2 2026 results and hospital-affiliation rollout. The company said Q2 revenue rose 8.5% to $214M, PT revenue rose 8.4% to $182M, and visits increased 6.6% to 1.662M. Net rate was $107.59. It cited $3.2M higher self-insured health care costs and expects clinic transitions to continue into Q3.

$USPHMed

U S PHYSICAL THERAPY INC /NV (USPH): Results of Operations and Financial Condition

U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CONTACT: U.S. Physical Therapy, Inc. Jason Curtis, Interim Chief Financial Officer email: jcurtis@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 USPH Reports Second Quarter 2026 Results, Reaffirms Full Yea